Fulcrum Therapeutics Reports Recent Business Highlights and Second Quarter 2020 Financial Results
– Conference call scheduled for 8:00 a.m. ET today –CAMBRIDGE, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: […]
Latest Release of Altair® PBS Professional® Offers Up to Tenfold Faster Performance for More Diverse and Dynamic HPC Workloads
TROY, Mich., Aug. 11, 2020 (GLOBE NEWSWIRE) — Altair (Nasdaq: ALTR), a global technology company providing solutions in product development, […]
Glory Star New Media Group Holdings Limited Releases Letter to Shareholders on Progress to Date and Future Growth Strategies
Beijing, Aug. 11, 2020 (GLOBE NEWSWIRE) — Glory Star New Media Group Holdings Limited (NASDAQ: GSMG, GSMGW) (“Glory Star” or […]
Aemetis Launches Aemetis Health Products Subsidiary
Company to offer Blended Liquid and Gel Hand Sanitizer as Bulk and Packaged ProductsCUPERTINO, CA, Aug. 11, 2020 (GLOBE NEWSWIRE) […]
aTyr Pharma Announces Partner Kyorin Pharmaceutical, Co., Ltd. Proceeds to Phase 1 Trial of ATYR1923 in Japan
SAN DIEGO, Aug. 11, 2020 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery […]
IAMGOLD Reports Remaining Assay Results and Extends the Renard System to the West at the Nelligan Gold Project, Quebec; Summer Drilling Program Underway
THIS PRESS RELEASE CANNOT BE DISTRIBUTED TO US PRESS WIRE SERVICES FOR BROADCAST USE IN THE UNITED STATES.MONTRÉAL, Aug. 11, […]
BetterLife Announces Closing of Private Placement
Vancouver, Aug. 11, 2020 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / […]
FirstCash Announces Commencement of Offering of Senior Notes
FORT WORTH, Texas , Aug. 11, 2020 (GLOBE NEWSWIRE) — FirstCash, Inc. (the “Company”) (Nasdaq: FCFS) today announced that it […]
Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
Merger between Chondrial Therapeutics and Zafgen completed and company began operating as Larimar TherapeuticsPhase 1 clinical trial of CTI-1601 for […]
Axovant Announces Corporate Updates and Financial Results for First Fiscal Quarter Ended June 30, 2020
Data readouts for AXO-Lenti-PD and AXO-AAV-GM1 remain on-track for Q4 2020Completed 3-year manufacturing and supply agreement with Oxford BioMedica for […]
